Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2017 2
2018 2
2020 1
2022 2
2023 1
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab for Early Triple-Negative Breast Cancer.
Schmid P, Cortes J, Pusztai L, McArthur H, Kümmel S, Bergh J, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Foukakis T, Fasching PA, Cardoso F, Untch M, Jia L, Karantza V, Zhao J, Aktan G, Dent R, O'Shaughnessy J; KEYNOTE-522 Investigators. Schmid P, et al. N Engl J Med. 2020 Feb 27;382(9):810-821. doi: 10.1056/NEJMoa1910549. N Engl J Med. 2020. PMID: 32101663 Clinical Trial.
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
Schmid P, Cortes J, Dent R, Pusztai L, McArthur H, Kümmel S, Bergh J, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Untch M, Fasching PA, Cardoso F, Andersen J, Patt D, Danso M, Ferreira M, Mouret-Reynier MA, Im SA, Ahn JH, Gion M, Baron-Hay S, Boileau JF, Ding Y, Tryfonidis K, Aktan G, Karantza V, O'Shaughnessy J; KEYNOTE-522 Investigators. Schmid P, et al. N Engl J Med. 2022 Feb 10;386(6):556-567. doi: 10.1056/NEJMoa2112651. N Engl J Med. 2022. PMID: 35139274 Clinical Trial.
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer.
Schmid P, Cortes J, Dent R, McArthur H, Pusztai L, Kümmel S, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Im SA, Untch M, Fasching PA, Mouret-Reynier MA, Foukakis T, Ferreira M, Cardoso F, Zhou X, Karantza V, Tryfonidis K, Aktan G, O'Shaughnessy J; KEYNOTE-522 Investigators. Schmid P, et al. N Engl J Med. 2024 Nov 28;391(21):1981-1991. doi: 10.1056/NEJMoa2409932. Epub 2024 Sep 15. N Engl J Med. 2024. PMID: 39282906 Clinical Trial.
Cancer immunology and melanoma immunotherapy.
Linck RDM, Costa RLP, Garicochea B. Linck RDM, et al. An Bras Dermatol. 2017 Nov-Dec;92(6):830-835. doi: 10.1590/abd1806-4841.201756511. An Bras Dermatol. 2017. PMID: 29364441 Free PMC article. Review.
Breast Cancer Treatment Delay in SafetyNet Health Systems, Houston Versus Southeast Brazil.
Shafaee MN, Silva LR, Ramalho S, Doria MT, De Andrade Natal R, Cabello V, Cons L, Pavanello M, Zeferino LC, Mano MS, Linck RDM, Batista LS, Pedro EP, De Paula BH, Zuca-Matthes G, Podany E, Makawita S, Ann Stewart K, Tsavachidis S, Tamimi R, Bondy M, Debord L, Ellis M, Bines J, Cabello C. Shafaee MN, et al. Among authors: linck rdm. Oncologist. 2022 May 6;27(5):344-351. doi: 10.1093/oncolo/oyac050. Oncologist. 2022. PMID: 35348756 Free PMC article.
Real-world treatment outcomes in HR+ HER2- metastatic breast cancer patients treated with CDK4/6 inhibitors: Results from a reference center in Brazil.
Queiroz MM, Sacardo KP, Ribeiro MF, Gadotti LL, Saddi R, Oliveira LJC, Linck RDM, Cruz MRS, Barroso-Sousa R, Sahade M, Correa TS, Mano MS, Suzuki DA, Shimada AK, Katz A. Queiroz MM, et al. Among authors: linck rdm. Cancer Treat Res Commun. 2023;35:100683. doi: 10.1016/j.ctarc.2023.100683. Epub 2023 Jan 19. Cancer Treat Res Commun. 2023. PMID: 36716534 Free article.
Characteristics and Survival Outcomes of Male Breast Cancer in Brazil: A Large Population-Based Study.
de Oliveira Frederice R, Pereira AAL, Arruda GV, Gouveia AG, de Andrade FEM, Mori LJ, Linck RDM, Shimada AK, Hanna SA, de Moraes FY, Marta GN. de Oliveira Frederice R, et al. Among authors: linck rdm. Clin Oncol (R Coll Radiol). 2024 Oct 5:S0936-6555(24)00415-1. doi: 10.1016/j.clon.2024.10.002. Online ahead of print. Clin Oncol (R Coll Radiol). 2024. PMID: 39443191
Value of Systemic Staging in Asymptomatic Early Breast Cancer.
Soares GP, Pereira AAL, Vilas Boas MS, Vaisberg VV, Magalhães MCF, Linck RDM, Mano MS. Soares GP, et al. Among authors: linck rdm. Rev Bras Ginecol Obstet. 2018 Jul;40(7):403-409. doi: 10.1055/s-0038-1666997. Epub 2018 Jul 10. Rev Bras Ginecol Obstet. 2018. PMID: 29991088 Free article. English.
TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias.
Asprino PF, Linck RDM, Cesar J, Freitas FP, Koyama FC, Riechelmann RSP, Costa FP, Hoff PMG, Galante PAF, Meyer D, Camargo AA, Sabbaga J. Asprino PF, et al. Among authors: linck rdm. Endocr Relat Cancer. 2018 Feb;25(2):L1-L5. doi: 10.1530/ERC-17-0286. Epub 2017 Nov 22. Endocr Relat Cancer. 2018. PMID: 29167182 Free PMC article. No abstract available.
11 results